CytoReason
About
CytoReason is a tech company transforming biopharma’s decision-making from trial and error to data-driven using an AI Platform of computational disease models. With its extensive database of public and proprietary data, the company maps human diseases – tissue by tissue and cell by cell. Researchers of all levels rely on CytoReason’s technology to make data-driven decisions across the drug development life cycle. Scientists can identify potential targets, prioritize indications, and stratify patient populations. Program leaders can compare drugs across multiple diseases or multiple drugs within a single disease. C-level executives can gain valuable tools to manage and optimize entire drug portfolios.
Specialties
Bioinformatics|Machine Learning|Data Science|Computational Drug Discovery|Target Discovery|Indication Prioritisation|Patient Stratification|Biomarker Discovery|Immune System|Cancer Immunotherapy|Combinations|Indications|Inflammatory Bowel Disease|Atopic Dermatitis|Cells